15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2026 | $239M | -$80M | 76.2% | -38.3% | -$40M | — | $153M |
| 2024 | $314M | -$20M | 76.3% | -4.0% | -$8M | — | $144M |
| 2023 | — | $21M | — | — | — | — | — |
| 2023 | $322M | $21M | 78.4% | 8.7% | -$4M | — | $183M |
| 2022 | $239M | $40M | 93.3% | 18.3% | $18M | — | $86M |
| 2021 | $230M | $28M | 77.5% | 14.5% | $30M | — | $200M |
| 2021 | — | $28M | — | — | — | — | — |
| 2021 | $163M | $6M | 72.4% | 4.1% | $13M | — | $152M |
| 2020 | $150M | $14M | 74.5% | 7.9% | $16M | — | $120M |
| 2018 | $124M | $5M | 73.8% | 5.3% | $11M | — | $104M |
| 2017 | $91M | -$2M | 70.9% | -4.0% | $2M | — | $19M |
| 2016 | $82M | -$12M | 70.8% | -15.4% | -$2M | — | $14M |
| 2016 | — | -$7M | — | — | -$4M | — | $13M |
| 2015 | — | -$8M | — | — | — | — | $13M |
| 2014 | — | $398000 | — | — | — | — | $23M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Apr '26 | $94M | $5M | 73.6% | 8.5% | -$22M | — | $132M |
| Jan '26 | $58M | -$18M | 75.7% | -39.5% | -$6M | — | $153M |
| Sep '25 | $95M | $9M | 82.2% | 19.5% | $2M | — | $176M |
| Jun '25 | $44M | -$17M | 74.0% | -67.6% | -$29M | — | $167M |
| Mar '25 | $43M | -$54M | 65.8% | -134.8% | -$7M | — | $173M |
| Dec '24 | $49M | -$34M | 64.7% | -57.0% | -$5M | — | $144M |
| Sep '24 | $89M | $10M | 77.3% | 6.4% | -$2M | — | $164M |
| Jun '24 | $99M | $7M | 79.2% | 12.0% | -$17M | — | $193M |
| Mar '24 | $77M | -$3M | 78.9% | -2.9% | $16M | — | $224M |
| Dec '23 | $76M | $8M | 79.6% | 13.6% | $29M | — | $183M |
| Sep '23 | $80M | $5M | 79.2% | 7.8% | -$15M | — | $127M |
| Jun '23 | $92M | $6M | 76.6% | 9.3% | -$9M | — | $95M |
| Mar '23 | $74M | $3M | 78.3% | 3.8% | -$8M | — | $90M |
| Dec '22 | $64M | $7M | 77.7% | 1.5% | -$1M | — | $86M |
| Sep '22 | $76M | $10M | 79.5% | 18.0% | $18M | — | $129M |
| Jul '22 | $81M | $13M | 78.8% | 21.0% | $8M | — | $202M |
| Apr '22 | $63M | $10M | 77.9% | 19.2% | -$7M | — | $193M |
| Dec '21 | $59M | $5M | 76.3% | 12.5% | $4M | — | $200M |
| Dec '21 | — | $8M | — | — | — | — | — |
| Oct '21 | $58M | $6M | 77.6% | 13.4% | $19M | — | $196M |
How the market has priced STAA against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Staar Surgical Co's revenue has grown 7.9% per year. These are computed facts, not advice.
As of FY2026, Staar Surgical Co reported — of total debt against $153M of cash.
In FY2026, gross margin was 76.2%, operating margin -38.3%, and net margin -33.6%.
As of Jun '26, Staar Surgical Co traded at a price-to-earnings ratio of about 67.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.